ID

33048

Description

This form contains a form to document the randomisation number, investigational products and the pharmacokinetics. To be assessed at the visits V1-3. Study ID: 103629 Clinical Study ID: TRX103629 Study Title: An open-label, randomized, 3-period crossover study to evaluate sumatriptan and naproxen pharmacokinetics for a combination tablet product containing sumatriptan/naproxen sodium followed by IMITREX™ (sumatriptan succinate) Injection 4mg administered using the IMITREX STATdose System and a sumatriptan/naproxen sodium tablet followed by IMITREX (sumatriptan succinate) Injection 6mg administered using the STATdose system compared with an IMITREX tablet 100mg followed by an IMITREX tablet 100mg Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00875784 Clinicaltrials.gov link: https://clinicaltrials.gov/ct2/show/NCT00875784 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: sumatriptan Trade Name: Imitrex ,Imiject ,Imigran; Imitrex,Imiject,Imigran Study Indication: Migraine Disorders

Lien

https://clinicaltrials.gov/ct2/show/NCT00875784

Mots-clés

Versions (3)
  1. 18/11/2018 18/11/2018 -
  2. 25/11/2018 25/11/2018 -
  3. 25/11/2018 25/11/2018 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

25 novembre 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Sumatriptan pharmacokinetics for TREXIMA/IMITREX NCT00875784

Anglais

Randomisation Number, Investigational Products, Pharmacokinetics Blood

1 Formulaires  
Administrative Data
Description

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject Identifier
Description

Subject Identifier

Type de données

integer

Alias
UMLS CUI [1]
C2348585
Date of Visit
Description

Date of Visit

Type de données

date

Alias
UMLS CUI [1]
C1320303
Visit Type
Description

Visit Type

Type de données

text

Alias
UMLS CUI [1]
C3641100
Randomisation Number (Only Visit 1)
Description

Randomisation Number (Only Visit 1)

Alias
UMLS CUI-1
C1300638
UMLS CUI-2
C0034656
Was the subject able to be randomised?
Description

Subject's randomisation

Type de données

boolean

Alias
UMLS CUI [1,1]
C1300638
UMLS CUI [1,2]
C0034656
In case the subject was able to be randomised, provide: Randomisation number
Description

Randomisation number

Type de données

text

Alias
UMLS CUI [1,1]
C1300638
UMLS CUI [1,2]
C0034656
In case the subject was able to be randomised, provide: Date of randomisation
Description

Date of randomisation

Type de données

date

Alias
UMLS CUI [1]
C0034656
Investigational Product
Description

Investigational Product

Alias
UMLS CUI-1
C0304229
Date/time of dose
Description

Date/time of dose

Type de données

datetime

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1264639
Treatment Confirmation
Description

Treatment Confirmation

Alias
UMLS CUI-1
C0750484
UMLS CUI-2
C0087111
Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
Description

Receivement of the correct treatment

Type de données

boolean

Alias
UMLS CUI [1,1]
C0750484
UMLS CUI [1,2]
C0087111
In case the subject did not receive the correct treatment: record reason(s)
Description

Reason(s) in case the subject did not receive the correct treatment

Type de données

text

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C3827420
UMLS CUI [1,3]
C0392360
Dosing Date and Time
Description

Dosing Date and Time

Alias
UMLS CUI-1
C0178602
UMLS CUI-2
C1264639
Dosing date/time
Description

Dosing date/time

Type de données

datetime

Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C1264639
Pharmacokinetics Blood
Description

Pharmacokinetics Blood

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0005767
Planend relative time
Description

Planned relative time of blood sample collection for pharmacokinetics analysis

Type de données

text

Alias
UMLS CUI [1,1]
C0439564
UMLS CUI [1,2]
C0031328
UMLS CUI [1,3]
C0005834
Actual time
Description

To be assessed for all timepoints up to 4 hours post-dose (included)

Type de données

time

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C0031328
UMLS CUI [1,3]
C0005834
Actual date/time
Description

To be assessed for all timepoints from 6 hours post-dose on (included).

Type de données

datetime

Alias
UMLS CUI [1,1]
C1264639
UMLS CUI [1,2]
C0031328
UMLS CUI [1,3]
C0005834
Retour au début de la page

Similar models

Randomisation Number, Investigational Products, Pharmacokinetics Blood

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Subject Identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Date of Visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
Item
Visit Type
text
C3641100 (UMLS CUI [1])
Visit Type
Code List
Visit Type
CL Item
V1 (V1)
CL Item
V2 (V2)
CL Item
V3 (V3)
Item Group
Randomisation Number (Only Visit 1)
C1300638 (UMLS CUI-1)
C0034656 (UMLS CUI-2)
Subject's randomisation
Item
Was the subject able to be randomised?
boolean
C1300638 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
Randomisation number
Item
In case the subject was able to be randomised, provide: Randomisation number
text
C1300638 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
Date of randomisation
Item
In case the subject was able to be randomised, provide: Date of randomisation
date
C0034656 (UMLS CUI [1])
Item Group
Investigational Product
C0304229 (UMLS CUI-1)
Date/time of dose
Item
Date/time of dose
datetime
C0304229 (UMLS CUI [1,1])
C1264639 (UMLS CUI [1,2])
Item Group
Treatment Confirmation
C0750484 (UMLS CUI-1)
C0087111 (UMLS CUI-2)
Receivement of the correct treatment
Item
Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
boolean
C0750484 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Reason(s) in case the subject did not receive the correct treatment
Item
In case the subject did not receive the correct treatment: record reason(s)
text
C0087111 (UMLS CUI [1,1])
C3827420 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
Item Group
Dosing Date and Time
C0178602 (UMLS CUI-1)
C1264639 (UMLS CUI-2)
Dosing date/time
Item
Dosing date/time
datetime
C0178602 (UMLS CUI [1,1])
C1264639 (UMLS CUI [1,2])
Item Group
Pharmacokinetics Blood
C0031328 (UMLS CUI-1)
C0005767 (UMLS CUI-2)
Item
Planend relative time
text
C0439564 (UMLS CUI [1,1])
C0031328 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,3])
Timepoint
Code List
Planend relative time
CL Item
Pre-dose (Pre-dose)
CL Item
0.5 hours (0.5 hours)
CL Item
0.75 hours (0.75 hours)
CL Item
1 hour (1 hour)
CL Item
1.5 hours (1.5 hours)
CL Item
2 hours (2 hours)
CL Item
2.17 hours (2.17 hours)
CL Item
2.25 hours (2.25 hours)
CL Item
2.5 hours (2.5 hours)
CL Item
2.75 hours (2.75 hours)
CL Item
3 hours (3 hours)
CL Item
4 hours (4 hours)
CL Item
6 hours (6 hours)
CL Item
8 hours (8 hours)
CL Item
10 hours (10 hours)
CL Item
12 hours (12 hours)
CL Item
14 hours (14 hours)
CL Item
24 hours (24 hours)
CL Item
48 hours (48 hours)
CL Item
72 hours (72 hours)
Actual time of blood sample collection for pharmacokinetics analysis
Item
Actual time
time
C0040223 (UMLS CUI [1,1])
C0031328 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,3])
Actual date/time of blood sample collection for pharmacokinetics analysis
Item
Actual date/time
datetime
C1264639 (UMLS CUI [1,1])
C0031328 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial